Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatin.
Menon NS, Noronha V, Patil VM, Joshi A, Bhattacharjee A, Kalra D, Laskar SG, Mathrudev V, Nawale K, Bhelekar AS, Prabhash K. Menon NS, et al. Among authors: laskar sg. Cancer Med. 2022 Nov;11(21):3939-3948. doi: 10.1002/cam4.4715. Epub 2022 Mar 28. Cancer Med. 2022. PMID: 35343648 Free PMC article. Clinical Trial.
Validation of recursive partitioning analysis classification in patients with brain metastases from non-small cell lung cancer treated with short-course accelerated radiotherapy.
Agarwal JP, Wadasadawala T, Munshi A, Chadda P, Apsani R, Upasani M, Laskar SG, Pramesh CS, Karimundackal G, Menon H, Prabhash K, Jambhekar N. Agarwal JP, et al. Among authors: laskar sg. Clin Oncol (R Coll Radiol). 2010 Dec;22(10):837-43. doi: 10.1016/j.clon.2010.05.022. Epub 2010 Jun 29. Clin Oncol (R Coll Radiol). 2010. PMID: 20591632
Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent platinum-based chemo-radiotherapy: Ready for routine clinical practice?
Agarwal JP, Gupta T, Kalyani N, Budrukkar A, Laskar SG, Murthy V, Kumar P, Narohna V, Pai P, Chaturvedi P, D'cruz AK. Agarwal JP, et al. Among authors: laskar sg. Indian J Cancer. 2011 Apr-Jun;48(2):148-53. doi: 10.4103/0019-509X.82872. Indian J Cancer. 2011. PMID: 21768657 Free article.
Guidelines for treatment of recurrent or metastatic head and neck cancer.
Parikh P, Patil V, Agarwal JP, Chaturvedi P, Vaidya A, Rathod S, Noronha V, Joshi A, Jamshed A, Bhattacharya GS, Gupta S, Desai C, Advani SH, Pai P, Laskar S, Ramesh A, Mohapatra PN, Vaid AK, Deshpande M, Ranade AA, Vora A, Baral R, Hussain MA, Rajan B, Dcruz AK, Prabhash K; Indian Cooperative Oncology Network. Parikh P, et al. Indian J Cancer. 2014 Apr-Jun;51(2):89-94. doi: 10.4103/0019-509X.137896. Indian J Cancer. 2014. PMID: 25104184 Free article. No abstract available.
A comparative analysis of immunohistochemistry and fluorescent in situ hybridization assay to detect anaplastic lymphoma kinase status in lung adenocarcinoma cases: A search for a testing algorithm.
Wagle PB, Jambhekar NA, Kumar R, Prabhash K, Pramesh CS, Desai SB, Noronha V, Karimundackal G, Shah A, Joshi A, Laskar SG, Jiwnani S, Pai T, Agarwal JP. Wagle PB, et al. Among authors: laskar sg. Indian J Cancer. 2017 Jan-Mar;54(1):148-154. doi: 10.4103/ijc.IJC_202_17. Indian J Cancer. 2017. PMID: 29199679 Free article.
A prospective study of telephonic contact and subsequent physical follow-up of radically treated lung cancer patients.
Mathew AS, Agarwal JP, Munshi A, Laskar SG, Pramesh CS, Karimundackal G, Jiwnani S, Prabhash K, Noronha V, Joshi A, Rangarajan V, Purandare NC, Jambhekar N, Tandon S, Mahajan A, Kumar R, Deodhar J. Mathew AS, et al. Among authors: laskar sg. Indian J Cancer. 2017 Jan-Mar;54(1):241-252. doi: 10.4103/0019-509X.219599. Indian J Cancer. 2017. PMID: 29199699 Free article.
140 results